Global Autoimmune Disease Treatment Market - By Disease Type, Diagonostics, Products, Region - Market Size, Demand Forecasts, Industry Trends and Updates (2016-2022)

  • ID: 4392242
  • Report
  • Region: Global
  • 135 pages
  • Oristep Consulting
25 % OFF
until Dec 31st 2018
1 of 4

FEATURED COMPANIES

  • 4SC AG
  • Active Biotech
  • AstraZeneca plc
  • Bayer
  • Bristol-Myers Squibb
  • F. Hoffmann-La Roche Ltd.
  • MORE
Autoimmune diseases occur when the immune system of an individual’s body treats healthy cells of his/her very own body as foreign cells and attacks them. These diseases causes variations in organ functioning, abnormal growth of organs and destruction of healthy body tissues. Autoimmune diseases are mostly chronic in nature and there is no curative therapy., Dermatomyositis, Type 1 diabetes Hashimoto’s disease, Sjogren's syndrome, Psoriasis are some of the examples of Autoimmune diseases. Systemic autoimmune diseases treatment and Localized autoimmune disease treatment are two types of autoimmune disease treatment.

Various types of treatments for these diseases include Physical therapy, blood transfusion, Recombinant technology, Chemo therapy, Topical therapy, TNF-a antagonists and Helminthic therapy. Women, generally, have higher incidences of these diseases compared to men.

Supply-Demand Scenario:

Global autoimmune diseases treatment market is estimated to grow at a CAGR of 3.80% for the forecasted period, and its market value is expected to reach $45.54 billion by 2022 from $36.41 billion in 2016

Growth by Region:

North America holds the major share in global autoimmune disease treatment market followed by Europe. North America market is expected to reach XX.XX billion, at a CAGR of X.X % for the forecasted period whereas Europe is expected to reach XX.XX billion by 2020 at a CAGR of X.X%.On the other hand, Asia-Pacific is expected to display rapid growth during the forecasted period.

Drivers Vs. Constraints:

Dominance of North America and Europe in autoimmune disease market can be attributed to factors like prevalence of autoimmune diseases, increasing investments in R&D and higher disposable income in these regions. Factors such as improving health infrastructure, increasing awareness among people about heath care and increasing aging populations are going to fuel the rapid growth of autoimmune disease treatment market in Asia-Pacific region in the next five years.

Availability of various biosimilar drugs, Government initiatives and support to restrict autoimmune diseases are also major factors contributing for the growth of this market. Lack of standardized treatment for these diseases, Poorly trained physicians, low medical insurance coverage and low levels of awareness among public about these diseases are some of the challenges for this industry.

Industry Structure and Updates:

This industry comprises price based intense competition among various players. Some of the major players operating in autoimmune disease treatment market include Abott Laboratories, Roche, Johnson&Johnson, Beckman Coulter Inc., Pfizer, Lupin Limited and GlaxoSmithKline plc.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • 4SC AG
  • Active Biotech
  • AstraZeneca plc
  • Bayer
  • Bristol-Myers Squibb
  • F. Hoffmann-La Roche Ltd.
  • MORE
1. Research Methodology

2. Executive Summary

3. Market Overview
  • Definition
  • Value Chain Analysis
  • Porter's 5 Forces
  • Regulations
4. Market Dynamics
  • Introduction
  • Drivers
  • Constraints
  • Opportunities
5. Global Autoimmune Disease Treatment Market Segmentation, Forecasts and Trends - By Revenue

6. By Disease type
  • Localized
  • Systemic
7. By Diagonostics
  • IFA
  • ELISA
  • Dot blot
  • Line blot
  • Aggultination
  • Double immune diffusion
  • Western Blotting
  • Multiplex immunoassay
  • Others
8. By Products
  • Drugs
  • Therapeutic and monitoring equipment
  • Diagonostic equipments
9. By Region
  • North America
  • U.S.
  • Canada
  • Europe
  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Switzerland
  • Others
  • Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Others
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Others
  • MEA
  • UAE
  • Saudi Arabia
  • South Africa
  • Others
10. Vendor Market Share Analysis

11. Company Profiles
  • Abbott Laboratories
  • Active Biotech
  • Eli Lilly
  • Bristol-Myers Squibb
  • AstraZeneca plc
  • Pfizer
  • Biogen Idec
  • Lupin Limited
  • GlaxoSmithKline
  • Amgen
  • 4SC AG
  • F. Hoffmann-La Roche Ltd.
  • AutoImmune Inc
  • Johnson & Johnson
  • Bayer
  • Others
12. Industry Structure
  • Industry M&As, Consolidations
  • Investment Opportunities
13. Global Autoimmune Disease Treatment market - Road Ahead
  • Tables
  • Disclaimer
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Abbott Laboratories
  • Active Biotech
  • Eli Lilly
  • Bristol-Myers Squibb
  • AstraZeneca plc
  • Pfizer
  • Biogen Idec
  • Lupin Limited
  • GlaxoSmithKline
  • Amgen
  • 4SC AG
  • F. Hoffmann-La Roche Ltd.
  • AutoImmune Inc
  • Johnson & Johnson
  • Bayer
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll